Your browser doesn't support javascript.
loading
Reply to the letter to the editor 'Toxicity adjustment in the ESMO-MCBS: a Gestalt approach?' by Del Paggio.
Cherny, N I; Dafni, U; Bogaerts, J; Latino, N J; Pentheroudakis, G; Douillard, J-Y; Tabernero, J; Zielinski, C; Piccart, M J; de Vries, E G E.
Affiliation
  • Cherny NI; Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. Electronic address: mcbs@esmo.org.
  • Dafni U; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens & Frontier Science Foundation-Hellas, Athens, Greece.
  • Bogaerts J; Methodology Direction, EORTC Headquarters, Brussels, Belgium.
  • Latino NJ; ESMO Head Office, Lugano, Switzerland.
  • Pentheroudakis G; Medical Oncology Department, Ioannina University Hospital, Ioannina, Greece.
  • Douillard JY; Methodology Direction, EORTC Headquarters, Brussels, Belgium.
  • Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Zielinski C; Division of Oncology, Medical University Vienna, Vienna, Austria.
  • Piccart MJ; Jules Bordet Institute, Universite Libre de Bruxelles, Brussels, Belgium.
  • de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Ann Oncol ; 29(2): 521-522, 2018 02 01.
Article in En | MEDLINE | ID: mdl-29045537
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Country of publication: United kingdom